Jan 18, 2017, 15:23 PM by Michael Croft

MIT Technology Review | Google and others think software that learns to learn could take over some work done by AI experts.

Jan 18, 2017, 09:37 AM by Michael Croft

ENDPOINTS NEWS | Thomson Reuters dug up investment numbers for all of the top 100 VCs investing in biotech, and Endpoints News ranked them. Flagship, Third Rock, New Enterprise Associates, and Arch Venture are the top four, and many of the top four players remain focused on early stage investment.

Jan 17, 2017, 11:07 AM by Michael Croft

CAMBRIDGE, UNITED KINGDOM - Jan 17, 2017 - Congenica, a world leading developer of genome analysis and interpretation technologies, expands its operations in the US with the announcement that it has recruited Dr Shikha O’Brien as its Chief Business Officer

Jan 16, 2017, 15:35 PM by Michael Croft

Bio-IT World Brief | Novogene today announced its intention to purchase 10 Sequel Systems for whole genome sequencing, Iso-Seq annotation and targeted sequencing services from Pacific Biosciences.

Jan 16, 2017, 13:40 PM by Michael Croft

The New York Times | Where are the miracle treatments we were promised? A Nobel Prize-winning scientist explains.

Jan 13, 2017, 14:08 PM by Michael Croft

ENDPOINTS NEWS | Vivek Ramaswamy blindsided the biotech industry with a record-setting IPO for the mystery biotech Axovant. The one-time hedge fund maestro turned drug entrepreneur has set up three more companies and taken one of them public at near supersonic speed, all while busily in-licensing drugs from a growing list of suppliers.

Jan 13, 2017, 07:38 AM by Michael Croft

BOSTON & LONDON, US & UK - Jan 12, 2017 - IDBS has today launched The E-WorkBook Cloud, an enterprise, Cloud-based platform designed specifically to meet the future challenges of scientific and R&D data management

Jan 12, 2017, 12:25 PM by Michael Croft

Bio-IT World Brief | The JP Morgan Healthcare Conference was held this week in San Francisco, kicking off 2017 with news and deals and product announcements. Many presentations were webcast. Here are some of the highlights and news bits we’ve collected over the past three days.

Jan 11, 2017, 04:52 AM by Michael Croft

SHIRLEY, NY, UNITED STATES - Jan 11, 2017 - Creative Peptides optimized its synthesis services by adding more specific peptide synthesis, and three categories are included-GMP peptide synthesis, glycopeptides synthesis, Cell-Penetrating Peptides Synthesis

Jan 10, 2017, 08:23 AM by Michael Croft

PRINCETON, NJ - Jan 10, 2017 - Certara®, the leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, today announced that it has released version 16 of its Simcyp® Population-based Simulator

Jan 9, 2017, 19:55 PM by Michael Croft

Bio-IT World Speaking at the J.P. Morgan Healthcare Conference this afternoon, Francis deSouza, President and CEO of Illumina, unveiled the NovaSeq series, a new and scalable sequencing architecture, comprised of two instruments: the NovaSeq 5000 and NovaSeq 6000.

Jan 9, 2017, 19:15 PM by Michael Croft

Forbes | What drugs is Moderna developing? It finally gives some details at JP Morgan.

Jan 9, 2017, 16:43 PM by Michael Croft

Diagnostics World | Last week PatientsLikeMe announced a partnership and investment from iCarbonX that positions PatientsLikeMe as the cornerstone of Jun Wang's iCarbonX Digital Life Alliance, which aims to digitize and analyze all aspects of life.

Jan 9, 2017, 15:51 PM by Michael Croft

Pacific Standard | Though the medical benefits of genome science have been marginal thus far, the government's multi-billion-dollar investment could pay off with the right policy adjustments.

Jan 9, 2017, 10:10 AM by Michael Croft

Bio-IT World | An epic CRISPR litigation battle between a host of universities has erupted involving CRISPR/Cas9, which can have major implications for the gene-editing technology community.

Jan 9, 2017, 06:48 AM by Michael Croft

NEW YORK, NY, USA - Jan 9, 2017 - Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced that the 2017 Reaxys PhD Prize is open for submissions from young chemists from institutions around the world

Jan 6, 2017, 10:55 AM by Michael Croft

Bio-IT World This week Synthego, a leading provider of genome engineering solutions, announced a $41 million Series B financing, bringing the company’s total fundraising to $50 million. The latest round includes investment from several venture firms, as well as direct, individual investments from Jennifer Doudna and Jamie Cate.

Jan 6, 2017, 09:26 AM by Michael Croft

HPCwire | Twenty years ago high performance computing was nearly absent from life sciences. Today it's used throughout life sciences and biomedical research. Genomics and the data deluge from modern lab instruments are the main drivers, but so is the longer-term desire to perform predictive simulation in support of Precision Medicine (PM).

Jan 5, 2017, 14:36 PM by Michael Croft

SEATTLE, WA, UNITED STATES - Jan 5, 2017 - Transform Research, LLC dba Bio Data Bridges, a life science software and knowledge management company, received a Phase I Small Business Innovation Research (SBIR) grant from the National Institute of General Medical Sciences (NIGMS)

Jan 5, 2017, 13:07 PM by Michael Croft

BRANFORD, CT, UNITED STATES - Jan 5, 2017 - Core Informatics today announced the release of two new genomics workflow solutions for use on the Platform for Science